Results 11 to 20 of about 17,499 (214)

Relationship between use of desmopressin in male patients with lower urinary tract symptoms and occurrence of hyponatremia: A nationwide population-based study using the National Health Insurance Service database [PDF]

Investigative and Clinical Urology
Purpose: Desmopressin, frequently prescribed for nocturia, is associated with an elevated risk of hyponatremia. This study examined the incidence and risk factors of hyponatremia in male patients with benign prostatic hyperplasia using nationwide Korean ...
Byeong Jo Jeon, Bum Sik Tae, Jae Young Park, Jae Hyun Bae   +3 more
doaj   +2 more sources

Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis

Perioperative Medicine
We systematically reviewed the literature to investigate the effects of peri-procedural desmopressin in patients without known inherited bleeding disorders undergoing surgery or other invasive procedures.
Carol Wang, Victoria Lebedeva, Jeffy Yang, Joshua Anih, Lily J. Park, Freeman Paczkowski, Pavel S. Roshanov   +6 more
doaj   +2 more sources

Use of Desmopressin in Hyponatremia: Foe and Friend

Kidney Medicine, 2019
Use of desmopressin (1-deamino-8-d-arginine vasopressin; DDAVP), a synthetic vasopressin receptor agonist, has expanded in recent years. Desmopressin leads to renal water retention, and iatrogenic hyponatremia may result if fluid intake is not ...
Steven G. Achinger, Juan Carlos Ayus
doaj   +2 more sources

Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study

Annals of Intensive Care, 2019
Background In traumatic brain injury (TBI) patients desmopressin administration may induce rapid decreases in serum sodium and increase intracranial pressure (ICP).
A. Harrois, J. R. Anstey, F. S. Taccone, A. A. Udy, G. Citerio, J. Duranteau, C. Ichai, R. Badenes, J. R. Prowle, A. Ercole, M. Oddo, A. Schneider, M. van der Jagt, S. Wolf, R. Helbok, D. W. Nelson, M. B. Skrifvars, D. J. Cooper, R. Bellomo, The TBI Collaborative   +19 more
doaj   +2 more sources

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

Blood Advances, 2019
: The bleeding phenotype of patients with type 1 von Willebrand disease (VWD) is very heterogeneous. We hypothesized that this heterogeneity may partly be explained by variability in response of von Willebrand factor (VWF) and factor VIII (FVIII) levels ...
Ferdows Atiq, Lisette M. Schütte, Agnes E.M. Looijen, Johan Boender, Marjon H. Cnossen, Jeroen Eikenboom, Moniek P.M. de Maat, Marieke J. H.A. Kruip, Frank W.G. Leebeek   +8 more
doaj   +2 more sources

Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A [PDF]

Haematologica
Desmopressin increases plasma factor VIII and von Willebrand factor in non-severe hemophilia A (Hem A) and type 1 von Willebrand disease (VWD), following intravenous infusions, subcutaneous injections or nasal spray.
Alessandro Gringeri, Pier Mannuccio Mannucci, Michele Gringeri, Giancarlo Castaman, Flora Peyvandi   +4 more
doaj   +2 more sources

Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post–Kidney Biopsy Bleeding [PDF]

Kidney International Reports
Introduction: This study evaluated the efficacy and safety of desmopressin in reducing postbiopsy bleeding in patients undergoing kidney biopsy, a common complication requiring effective prevention strategies.
Narayan Prasad, Jeyakumar Meyyappan, Deependra Kumar Yadav, Brijesh Yadav, Ravi Kushwaha, Manas Patel, Vamsidhar Veeranki, Dharmendra Bhadauria, Manas Behera, Monika Yachha, Anupama Kaul, Jai Kishun, Dheeraj Khetan, Anupam Verma, Heera Lal   +14 more
doaj   +2 more sources

Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience [PDF]

Endocrine Connections
Omissions or delays in desmopressin can result in serious patient harm in patients with arginine vasopressin deficiency (AVP-D), formally known as cranial diabetes insipidus.
Muhammad Fahad Arshad, Sam Solanki, Luka Dancyger-Stevens, Madushani Karunanayaka, Ee-Wen Loh, Kyaw Naing Htoon, Mohanad Turki, Alia Munir   +7 more
doaj   +2 more sources

Use of the Desmopressin Clamp in Hyponatremia: Smooth Sailing or Turbulent Waters? [PDF]

Kidney360
Phekoo A, Sparks MA.
europepmc   +2 more sources

Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta‐analysis of randomized controlled trials

Journal of Thrombosis and Haemostasis, 2017
Michael Desborough
exaly   +2 more sources